Last edition
News about Global Pharma
4Moving Biotech Secures EUR 7.6M France 2030 Grant to Advance Osteoarthritis Drug
4MB's selection is a significant endorsement, granted through a rigorous, multi-stage evaluation process by leading scientific, clinical, and technological experts.
Global Pharma | 08/04/2025 | By Abha | 284
Dr JB Sharma Appointed as Head of Obstetrics & Gynaecology at Yashoda Medicity
Dr. J.B. Sharma is well-recognised for his work in Obstetrics and Gynaecology. He is in the top 2 percent of leading doctors in the world as per Stanford University.
Global Pharma | 08/04/2025 | By Abha | 841
ICU Medical Receives FDA Clearance for Plum Solo IV Pump, Expanding IV Performance Platform
ICU Medical Inc. has announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo™ precision IV pump, a single-channel complement to the dual-channel Plum Duo™.
Global Pharma | 07/04/2025 | By Manvi | 327
Sun Pharma Launches Novel Drug in India for Treatment of Erosive Esophagitis
Sun Pharmaceutical Industries Ltd. has launched FEXUCLUE (Fexuprazan 40 mg), a novel treatment for Erosive Esophagitis, in India under a licensing agreement with Korea’s Daewoong Pharmaceutical.
Global Pharma | 07/04/2025 | By Manvi | 627
The Nelipak® medical packaging product lineup includes a comprehensive range of custom designed sterile-barrier packaging solutions.
Global Pharma | 07/04/2025 | By Aishwarya | 358
Amneal Launches BORUZU for Multiple Myeloma and Mantle Cell Lymphoma
BORUZU™ (bortezomib injection), a proteasome inhibitor, is used for the treatment of multiple myeloma and mantle cell lymphoma.
Global Pharma | 07/04/2025 | By Aishwarya | 350
Centrient Pharmaceuticals Join Hands with Computer Shiksha to Transform Education in Punjab
By addressing the lack of digital education resources in these schools, the partnership between Centrient Pharmaceuticals and Computer Shiksha is paving the way for a more inclusive and digitally empowered society.
Global Pharma | 07/04/2025 | By Aishwarya | 218
Glenmark Appoints Anurag Mantri as President
Mantri brings over 30 years of leadership experience across corporate finance, IPOs, M&A, and global compliance.
Global Pharma | 07/04/2025 | By Aishwarya | 312
UPLIZNA Becomes First and Only FDA-Approved Therapy for IGG4-Related Disease
The FDA granted Breakthrough Therapy Designation to UPLIZNA for the treatment of IgG4-RD, recognising the high unmet medical need in this serious condition and the medicine's potential to benefit patients.
Global Pharma | 05/04/2025 | By Abha | 441
Dr. Sanjay Keswani to Lead Medical Strategy at Neurocrine Biosciences as New CMO
Dr. Keswani, who has more than 20 years of pharmaceutical industry experience with broad R&D expertise in multiple therapeutic areas, will lead the clinical development and medical affairs activities at Neurocrine.
Global Pharma | 05/04/2025 | By Abha | 443
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy